-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCE-WEEKLY TRANSCON® CNP (NAVEPEGRITIDE) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF ACHONDROPLASIA IN CHILDREN

Reuters·10/16/2026 12:29:53

Please log in to view news